Company-led recall: EXS Delay Spray Plus

LTC Healthcare has informed the MHRA that they have been selling a medicinal product containing lidocaine without authorisation from the MHRA.

MHRA Drug alert date: 13th November 2024

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/company-led-medicines-recall-leeds-trading-company-ltc-ltd-t-slash-a-ltc-healthcare-exs-delay-spray-plus-clmr-24-a-slash-01?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=f8d41c6d-9823-4127-9e84-7c0ff605722f&utm_content=immediately

Further Information

For medical information enquiries, please contact Andy Taylor, Managing Director:

Email: andy@ltchealthcare.co.uk

Telephone: 01423 326687

For stock information enquiries, please contact Andy Taylor, Managing Director:

Email: andy@ltchealthcare.co.uk

Telephone: 01423 326687

Class 4 caution in use-Omeprazole 40mg Powder for solution for infusion

Generics (U.K.) Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in specific batches of Omeprazole 40 mg Powder for solution for infusion do not contain the most up to date safety information.

MHRA Drug alert date: 12th November 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-viatris-uk-healthcare-ltd-omeprazole-40-mg-powder-for-solution-for-infusion-el-24-a-slash-54?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=b6521847-f0ea-4fbc-adc8-ba74059c9b3b&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information and stock control queries please contact:

Viatris UK Healthcare Limited Medical Information at +44 (0)1707 853 000 (select option 1) or info.uk@viatris.com. Customer Services can be reached at +44 (0)1707 853 000 (select option 2).

Class 4 caution in use-Zoledronic acid 4mg/5ml Solution

Ennogen Healthcare Limited has identified that action had not been taken to ensure the Patient Reminder Card (PRC) was distributed alongside the packs of product as part of the approved Additional Risk Minimisation Measures (RMM).

MHRA Drug alert date: 7th November 2024

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-ennogen-healthcare-limited-zoledronic-acid-ennogen-4mg-slash-5ml-concentrate-for-solution-for-infusion-el-24-a-slash-53?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=ae0d646e-30a4-4189-8027-c36d2c450c0b&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please contact MedicalInformation@ennogen.com

For stock control enquiries please telephone +44 (0)1322 629220

Happy Diwali from all at Alliance Healthcare UK

As we celebrate Diwali, symbolising the victory of good over evil and light over darkness, Marie Evans, Managing Director, Alliance Healthcare UK joins healthcare leaders in sharing their Diwali messages for Pharmacy Business magazine.

Read the piece here 👉 https://lnkd.in/ez9HPj8d (pages 38-39)

”Diwali carries a message that resonates deeply this year. It serves as a reminder of the rich diversity that strengthens our communities and the importance of coming together to celebrate each other's traditions and cultures.”

For all those who celebrate, may this Diwali bring you and your loved one’s joy, success, and good health 🪔✨

Class 2 recall-Labetalol 200mg tablets

Tillomed Laboratories Limited is recalling one batch of Labetalol 200mg Tablets as a precautionary measure due to potential mix-up at the manufacturing site.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-tillomed-laboratories-limited-labetalol-200mg-tablets-el-24-a-slash-52?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=2e33e9ba-323e-48e8-a188-eb6c601fda3b&utm_content=immediately

Further Information

For all medical enquiries, please contact Tillomed Laboratories Limited by email at either medical.information@tillomed.co.uk or PVUK@tillomed.co.uk, or telephone 0800 9706115.

For enquiries relating to stock returns please email Tillomed Laboratories Limited customer services customer.service@tillomed.com or telephone 01480 402 400.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Parasolve 500mg

Kent Pharma UK has identified an error in the Patient Information Leaflet (PIL) for Paracetamol 500mg Effervescent Tablets.

MHRA Drug alert date: 28th October 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-kent-pharma-uk-parasolve-paracetamol-500mg-effervescent-tablets-el-24-a-slash-51?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=5872b8d6-4416-46db-b971-7547e5419b92&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please contact medical@kent-athlone.com

For stock control enquiries please contact customer.service@kent-athlone.com

Alliance Healthcare UK to enter into a new reduced wholesale agreement with Besins Healthcare – 1 November 2024

We are pleased to announce that, as of 1 November 2024, Alliance Healthcare UK has become the only chosen wholesaler to supply selected products of Besins Healthcare’s portfolio to pharmacies, hospitals, and doctors in the United Kingdom, including Northern Ireland.

Click here for full product details

Class 2 recall-Phenobarbital tabs 15mg Bristol

Bristol Laboratories Ltd. are recalling one batch of Phenobarbital Bristol Labs 15mg Tablets as a precautionary measure due to the potential of contamination of small metallic particles within the tablets.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-bristol-laboratories-ltd-phenobarbital-bristol-labs-15mg-tablets-el-24-a-slash-50?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=7ae4cb12-a098-4a7b-84d5-cf21de226896&utm_content=immediately

Further Information

For medical information enquiries please contact: Notifications@bristol-labs.co.uk

For stock control enquiries please contact: Notifications@bristol-labs.co.uk

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Paracetamol 500mg effervescent tablets Kent Pharma

Kent Pharma UK has identified an error in the Patient Information Leaflet (PIL) for Paracetamol 500mg Effervescent Tablets.

MHRA Drug alert date: 21st October 2024

MHRA drug alert linkhttps://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-kent-pharma-uk-paracetamol-500mg-effervescent-tablets-el-24-a-slash-49?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=5a1672aa-08cf-4721-b0cb-ba1f21ce6982&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please contact medical@kent-athlone.com

For stock control enquiries please contact customer.service@kent-athlone.com

Class 4 caution in use-Linezolid 600mg tablets

Sandoz Ltd. has informed the MHRA that there is missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for Linezolid 600 mg film-coated tablets.

MHRA Drug alert date: 10th October 2024

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-sandoz-ltd-dot-linezolid-600-mg-film-coated-tablets-el-24-a-slash-48?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=025d6ab9-9885-40e6-ab69-13bedf8bcd94&utm_content=immediately

This is a caution in use only we are not accepting stock returns

Further Information

For medical information queries, please contact: sandozgb@EU.propharmagroup.com, Telephone: +44 1276 698 101.

For stock control queries, please contact: sales.sandoz-gb@sandoz.com, Telephone: +44 1276 698607.